TRDA20251219P12.5
TRDA Dec 19 2025 12.50 Put (TRDA251219P00012500)
option OPRA

entrada therapeutics is building the leading intracellular biologics company to transform the treatment of devastating diseases. entrada was co-founded in 2016 by 5am ventures, a leading life sciences venture capital firm.